US Patent Issued to NURIX THERAPEUTICS on April 7 for "CBL inhibitors and compositions for expansion of immune cells" (California Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,263, issued on April 7, was assigned to NURIX THERAPEUTICS INC. (San Francisco).

"CBL inhibitors and compositions for expansion of immune cells" was invented by Jennifa Gosling (San Francisco), Arthur T. Sands (San Francisco), Sarah Anne Whelan (San Francisco) and Michael Lotze (San Francisco).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods and compositions using novel Cbl inhibitors enhancing expansion of immune cells to increase the efficacy of cell-based immunotherapeutics are disclosed. Also provided are cell-based immunotherapy methods and compositions."

The patent was filed on Sept. 23, 2020, under Application No. 17/030,258.

*For furt...